BridgeBio Pharma, Inc. (BBIO) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$64.5
Day's range
$66.37

BridgeBio Pharma Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 05/13/2026 14.21 M $1.06 B   -2.35% 7.20%
KOHLBERG KRAVIS ROBERTS & CO. L.P. 05/15/2026 13.26 M $984.76 M   0.00% 6.72%
JANUS HENDERSON GROUP PLC 05/18/2026 13.18 M $978.61 M   19.80% 6.68%
VIKING GLOBAL INVESTORS LP 05/15/2026 11.84 M $879.42 M   -17.73% 6.00%
FARALLON CAPITAL MANAGEMENT LLC 05/15/2026 9.37 M $695.48 M   4.08% 4.75%
05/08/2026 8.08 M $600.06 M   100.00% 4.10%
05/15/2026 7.76 M $576.22 M   100.00% 3.93%
AISLING CAPITAL MANAGEMENT LP 05/05/2026 5.09 M $377.95 M   0.00% 2.58%
STATE STREET CORP 05/15/2026 4.93 M $366.42 M   -0.58% 2.50%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 4.92 M $371.93 M   11.46% 2.49%
INVESCO LTD. 05/12/2026 4.59 M $341.06 M   -4.94% 2.33%
UBS GROUP AG 05/05/2026 3.86 M $286.90 M   0.00% 1.96%
PRICE T ROWE ASSOCIATES INC /MD/ 05/15/2026 3.80 M $282.31 M   -0.71% 1.93%
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 05/15/2026 3.45 M $256.06 M   -2.75% 1.75%
CITADEL ADVISORS LLC 05/15/2026 3.17 M $235.70 M   354.60% 1.61%
TWO SIGMA INVESTMENTS, LP 05/15/2026 3.12 M $231.74 M   60.28% 1.58%
JANE STREET GROUP, LLC 05/12/2026 3.10 M $230.14 M   -9.30% 1.57%
D. E. SHAW & CO., INC. 05/15/2026 2.55 M $189.03 M   14.97% 1.29%
POLAR CAPITAL HOLDINGS PLC 05/15/2026 2.52 M $187.08 M   93.89% 1.28%
WELLINGTON MANAGEMENT GROUP LLP 05/15/2026 2.48 M $184.46 M   5.76% 1.26%
FRANKLIN RESOURCES INC 05/13/2026 2.44 M $181.11 M   12.66% 1.24%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 2.38 M $177.08 M   -10.70% 1.21%
FMR LLC 05/15/2026 2.34 M $174.05 M   -1.95% 1.19%
UBS GROUP AG 05/05/2026 2.03 M $150.51 M   8.06% 1.03%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 05/15/2026 1.98 M $146.82 M   0.09% 1.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 1.98 M $146.74 M   0.59% 1.00%
ALLIANCEBERNSTEIN L.P. 05/15/2026 1.91 M $146.01 M   -6.92% 0.97%
GOLDMAN SACHS GROUP INC 05/15/2026 1.90 M $140.92 M   6.44% 0.96%
MORGAN STANLEY 05/15/2026 1.88 M $139.41 M   34.12% 0.95%
SC US (TTGP), LTD. 05/14/2026 1.86 M $138.15 M   0.00% 0.94%
JANE STREET GROUP, LLC 05/12/2026 1.76 M $130.52 M   414.25% 0.89%
MACQUARIE MANAGEMENT HOLDINGS, INC. 05/15/2026 1.53 M $113.97 M   -11.04% 0.78%
NORTHERN TRUST CORP 05/14/2026 1.40 M $104.23 M   4.22% 0.71%
PICTET ASSET MANAGEMENT HOLDING SA 04/22/2026 1.38 M $101.49 M   8.73% 0.70%
PRINCIPAL FINANCIAL GROUP INC 05/04/2026 1.33 M $98.80 M   1.23% 0.67%
JPMORGAN CHASE & CO 05/13/2026 1.31 M $91.02 M   52.77% 0.67%
BNP PARIBAS ARBITRAGE, SNC 05/12/2026 1.31 M $97.07 M   -17.93% 0.66%
BANK OF AMERICA CORP /DE/ 05/18/2026 1.29 M $95.48 M   19.27% 0.65%
HOOD RIVER CAPITAL MANAGEMENT LLC 05/15/2026 1.27 M $93.94 M   0.79% 0.64%
LAURION CAPITAL MANAGEMENT LP 05/14/2026 1.26 M $93.76 M   -9.95% 0.64%
AMERIPRISE FINANCIAL INC 05/15/2026 1.25 M $92.72 M   48.36% 0.63%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 1.18 M $87.27 M   100.00% 0.60%
DRIEHAUS CAPITAL MANAGEMENT LLC 05/15/2026 1.15 M $85.15 M   -31.79% 0.58%
AMERICAN CENTURY COMPANIES INC 05/15/2026 1.09 M $80.97 M   -1.49% 0.55%
LORD, ABBETT & CO. LLC 05/14/2026 1.02 M $75.99 M   30.97% 0.52%
GW&K INVESTMENT MANAGEMENT, LLC 05/13/2026 962.64 K $71.49 M   53.75% 0.49%
FRONTIER CAPITAL MANAGEMENT CO LLC 05/15/2026 957.99 K $71.14 M   15.96% 0.49%
CLEARBRIDGE INVESTMENTS, LLC 05/13/2026 951.20 K $70.64 M   90.88% 0.48%
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC 05/05/2026 889.36 K $66.21 M   -10.55% 0.45%
CORMORANT ASSET MANAGEMENT, LP 05/15/2026 850.00 K $63.12 M   -29.17% 0.43%

BridgeBio Pharma Inc institutional Ownership - FAQ's

During the previous two years, 556 institutional investors and hedge funds held shares of BridgeBio Pharma Inc. The most heavily invested institutionals were:

BlackRock, Inc.: 14.21 M

Kohlberg Kravis Roberts & Co. L.P.: 13.26 M

JANUS HENDERSON GROUP PLC: 13.18 M

VIKING GLOBAL INVESTORS LP: 11.84 M

FARALLON CAPITAL MANAGEMENT LLC: 9.37 M

Aisling Capital Management LP: 5.09 M

98.68% of BridgeBio Pharma Inc stock is owned by institutional investors.

Institutional investors have bought a total of 219.20 M shares in the last 24 months. This purchase volume represents approximately $14.39 B in transactions.